UBS AM
ZOM

UBS AM’s Zomedica Corp. ZOM Stock Holding History

UBS AM’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-655,130
Closed -$221K – 2846
2022
Q1 		$221K Sell
655,130
-766,008
-54% -$251K ﹤0.01% 2658
2021
Q4 		$436K Buy
1,421,138
+859,818
+153% +$387K ﹤0.01% 2605
2021
Q3 		$294K Hold
561,320
– – ﹤0.01% 2622
2021
Q2 		$467K Buy
+561,320
New +$523K ﹤0.01% 2564

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

UBS AM's ZOM Position: Q2 2022 in Review

UBS AM sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 655,130 shares — an estimated $221K sold.

UBS AM first reported a position in ZOM in Q2 2021 and held it in 4 quarters. The position peaked at $467K in Q2 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

  • UBS AM reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 655,130 Zomedica Corp. shares in Q2 2022, an estimated $221K.
  • UBS AM first reported a position in Zomedica Corp. in Q2 2021 and held it in 4 quarters.
  • UBS AM's Zomedica Corp. position peaked at $467K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.